This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics US
December 15 - 18, 2024
Marriott Marquis San DiegoLive In-Person Event: December 15 - 18, 2024

Jerome Boyd-Kirkup, Ph.D.
Chief Scientific Officer and Co-Founder at Hummingbird Bioscience


Jerome Boyd-Kirkup is Chief Scientific Officer and co-founder of Hummingbird Bioscience, a data-driven precision biotherapeutics company discovering and developing transformative biologic medicines for hard-to-treat diseases. With a passion for integrating scientific disciplines, Jerome co-founded Hummingbird Bioscience to translate systems biology into transformative solutions in precision medicine. Jerome is responsible for overseeing the development of new technologies and intellectual property, designing experimental strategies for drug discovery, leading the development and testing of novel therapeutics, and overseeing the drug pipeline.

Jerome is a molecular systems biologist by background with extensive experience at the interface of computational and wet lab biology, and a career research focus of applying systems biology approaches to tackle human disease.

He holds a Bachelor's and Master's degree in Biochemistry from Imperial College London and a PhD in Molecular Biology from Cambridge University.

Agenda Sessions

  • Targeting the Novel Immune Checkpoint VISTA Using a Rational Antibody Development Strategy